Serrated colorectal polyps and the serrated neoplastic pathway: Emerging concepts in colorectal carcinogenesis

Current Diagnostic Pathology

Volumn 13, Issue 6, 2007, Pages 456-466

  Yantiss, Rhonda K ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

BRAF; DNA hypermethylation; Hyperplastic polyp; KRAS; Microsatellite instability; Mixed polyp; Serrated adenoma

Indexed keywords

METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; MITOGEN ACTIVATED PROTEIN KINASE;

ARTICLE; BRAF GENE; CHROMOSOMAL INSTABILITY; COLON CARCINOGENESIS; COLON POLYP; COLORECTAL CARCINOMA; DNA METHYLATION; GENE; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE MUTATION; GENE SILENCING; HETEROZYGOSITY LOSS; HMLH 1 GENE; HUMAN; MICROSATELLITE INSTABILITY; PROMOTER REGION; RECTUM POLYP; SERRATED COLORECTAL POLYP;

EID: 35848961653     PISSN: 09686053     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cdip.2007.06.006     Document Type: Article

References (51)

1. Tighe A., Johnson V.L., and Taylor S.S. Truncating APC mutations have dominant effects on proliferation, spindle checkpoint control, survival and chromosome stability. J Cell Sci 117 (2004) 6339-6353
2. Vogelstein B., Fearon E.R., Hamilton S.R., et al. Genetic alterations during colorectal-tumor development. N Engl J Med 319 (1988) 525-532
3. O'Brien M.J., Yang S., Mack C., et al. Comparison of microsatellite instability, CpG island methylation phenotype, BRAF and KRAS status in serrated polyps and traditional adenomas indicates separate pathways to distinct colorectal carcinoma end points. Am J Surg Pathol 30 (2006) 1491-1501
4. Lothe R.A., Peltomaki P., Meling G.I., et al. Genomic instability in colorectal cancer: relationship to clinicopathological variables and family history. Cancer Res 53 (1993) 5849-5852
5. Thibodeau S.N., Bren G., and Schaid D. Microsatellite instability in cancer of the proximal colon. Science 260 (1993) 816-819
6. Shia J., Ellis N.A., Paty P.B., et al. Value of histopathology in predicting microsatellite instability in hereditary nonpolyposis colorectal cancer and sporadic colorectal cancer. Am J Surg Pathol 27 (2003) 1407-1417
7. Markowitz S., Wang J., Myeroff L., et al. Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability. Science 268 (1995) 1336-1338
8. Rampino N., Yamamoto H., Ionov Y., et al. Somatic frameshift mutations in the BAX gene in colon cancers of the microsatellite mutator phenotype. Science 275 (1997) 967-969
9. Umar A., Boland C.R., Terdiman J.P., et al. Revised Bethesda guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst 96 (2004) 261-268
10. Ogino S., Cantor M., Kawasaki T., et al. CpG island methylator phenotype (CIMP) of colorectal cancer is best characterised by quantitative DNA methylation analysis and prospective cohort studies. Gut 55 (2006) 1000-1006
11. Slattery M.L., Curtin K., Anderson K., et al. Associations between cigarette smoking, lifestyle factors, and microsatellite instability in colon tumors. J Natl Cancer Inst 92 (2000) 1831-1836
12. Weisenberger D.J., Siegmund K.D., Campan M., et al. CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer. Nat Genet 38 (2006) 787-793
13. Goldman H., Ming S., and Hickock D.F. Nature and significance of hyperplastic polyps of the human colon. Arch Pathol 89 (1970) 349-354
14. Leggett B.A., Devereaux B., Biden K., Searle J., Young J., and Jass J. Hyperplastic polyposis: association with colorectal cancer. Am J Surg Pathol 25 (2001) 177-184
15. Beach R., Chan A.O., Wu T.T., et al. BRAF mutations in aberrant crypt foci and hyperplastic polyposis. Am J Pathol 166 (2005) 1069-1075
16. Jass J.R., Iino H., Ruszkiewicz A., et al. Neoplastic progression occurs through mutator pathways in hyperplastic polyposis of the colorectum. Gut 47 (2000) 43-49
17. Goldstein N.S. Small colonic microsatellite unstable adenocarcinomas and high-grade epithelial dysplasias in sessile serrated adenoma polypectomy specimens: a study of eight cases. Am J Clin Pathol 125 (2006) 132-145
18. Makinen M.J., George S.M., Jernvall P., Makela J., Vihko P., and Karttunen T.J. Colorectal carcinoma associated with serrated adenoma-prevalence, histological features, and prognosis. J Pathol 193 (2001) 286-294
19. Kambham N., Troxell M., and Longacre T.A. Multinucleated epithelial giant cells in colorectal polyps: a potential mimic of viropathic and/or dysplastic changes. Am J Surg Pathol 29 (2005) 912-919
20. Yantiss R.K., Goldman H., and Odze R.D. Hyperplastic polyp with epithelial misplacement (inverted hyperplastic polyp): a clinicopathologic and immunohistochemical study of 19 cases. Mod Pathol 14 (2001) 869-875
21. Shepherd N.A. Inverted hyperplastic polyposis of the colon. J Clin Pathol 46 (1993) 56-60
22. Sobin L.H. Inverted hyperplastic polyps of the colon. Am J Surg Pathol 9 (1985) 265-272
23. Torlakovic E., Skovlund E., Snover D.C., Torlakovic G., and Nesland J.M. Morphologic reappraisal of serrated colorectal polyps. Am J Surg Pathol 27 (2003) 65-81
24. Yashiro M., Laghi L., Saito K., et al. Serrated adenomas have a pattern of genetic alterations that distinguishes them from other colorectal polyps. Cancer Epidemiol Biomarkers Prev 14 (2005) 2253-2256
25. Yang S., Farraye F.A., Mack C., Posnik O., and O'Brien M.J. BRAF and KRAS mutations in hyperplastic polyps and serrated adenomas of the colorectum: relationship to histology and CpG island methylation status. Am J Surg Pathol 28 (2004) 1452-1459
26. O'Brien M.J., Yang S., Clebanoff J.L., et al. Hyperplastic (serrated) polyps of the colorectum: relationship of CpG island methylator phenotype and K-ras mutation to location and histologic subtype. Am J Surg Pathol 28 (2004) 423-434
27. Spring K.J., Zhao Z.Z., Karamatic R., et al. High prevalence of sessile serrated adenomas with BRAF mutations: a prospective study of patients undergoing colonoscopy. Gastroenterology 131 (2006) 1400-1407
28. Montgomery E. Serrated colorectal polyps: emerging evidence suggests the need for a reappraisal. Adv Anat Pathol 11 (2004) 143-149
29. Odze R.D., Batts K., Goldstein N., et al. Interobserver variability in the diagnosis of hyperplastic and serrated colonic polyps. Mod Pathol 20 Suppl. 2 (2007) 125A
30. Kambara T., Simms L.A., Whitehall V.L., et al. BRAF mutation is associated with DNA methylation in serrated polyps and cancers of the colorectum. Gut 53 (2004) 1137-1144
31. Higuchi T., Sugihara K., and Jass J.R. Demographic and pathological characteristics of serrated polyps of colorectum. Histopathology 47 (2005) 32-40
32. Wynter C.V., Walsh M.D., Higuchi T., Leggett B.A., Young J., and Jass J.R. Methylation patterns define two types of hyperplastic polyp associated with colorectal cancer. Gut 53 (2004) 573-580
33. Longacre T.A., and Fenoglio-Preiser C.M. Mixed hyperplastic adenomatous polyps/serrated adenomas. A distinct form of colorectal neoplasia. Am J Surg Pathol 14 (1990) 524-537
34. Yantiss R.K., Oh K.Y., Chen Y., Redston M., and Odze R.D. "Filiform" serrated adenomas: a clinicopathologic and immunophenotypic study of 18 cases. Am J Surg Pathol 31 (2007) 1238-1245
35. Dehari R. Infrequent APC mutations in serrated adenoma. Tohoku J Exp Med 193 (2001) 181-186
36. Hiyama T., Yokozaki H., Shimamoto F., et al. Frequent p53 gene mutations in serrated adenomas of the colorectum. J Pathol 186 (1998) 131-139
37. Konishi K., Yamochi T., Makino R., et al. Molecular differences between sporadic serrated and conventional colorectal adenomas. Clin Cancer Res 10 (2004) 3082-3090
38. Sawyer E.J., Cerar A., Hanby A.M., et al. Molecular characteristics of serrated adenomas of the colorectum. Gut 51 (2002) 200-206
39. Oh K., Redston M., and Odze R.D. Support for hMLH1 and MGMT silencing as a mechanism of tumorigenesis in the hyperplastic-adenoma-carcinoma (serrated) carcinogenic pathway in the colon. Hum Pathol 36 (2005) 101-111
40. Dong S.M., Lee E.J., Jeon E.S., Park C.K., and Kim K.M. Progressive methylation during the serrated neoplasia pathway of the colorectum. Mod Pathol 18 (2005) 170-178
41. Park S.J., Rashid A., Lee J.H., Kim S.G., Hamilton S.R., and Wu T.T. Frequent CpG island methylation in serrated adenomas of the colorectum. Am J Pathol 162 (2003) 815-822
42. Lee E.J., Choi C., Park C.K., et al. Tracing origin of serrated adenomas with BRAF and KRAS mutations. Virchows Arch 447 (2005) 597-602
43. Iino H., Jass J.R., Simms L.A., et al. DNA microsatellite instability in hyperplastic polyps, serrated adenomas, and mixed polyps: a mild mutator pathway for colorectal cancer?. J Clin Pathol 52 (1999) 5-9
44. Jass J.R., Baker K., Zlobec I., et al. Advanced colorectal polyps with the molecular and morphological features of serrated polyps and adenomas: concept of a 'fusion' pathway to colorectal cancer. Histopathology 49 (2006) 121-131
45. Sheridan T.B., Fenton H., Lewin M.R., et al. Sessile serrated adenomas with low- and high-grade dysplasia and early carcinomas: an immunohistochemical study of serrated lesions "caught in the act". Am J Clin Pathol 126 (2006) 564-571
46. Goldstein N.S., Bhanot P., Odish E., and Hunter S. Hyperplastic-like colon polyps that preceded microsatellite-unstable adenocarcinomas. Am J Clin Pathol 119 (2003) 778-796
47. Goldstein N.S. Serrated pathway and APC (conventional)-type colorectal polyps: molecular-morphologic correlations, genetic pathways, and implications for classification. Am J Clin Pathol 125 (2006) 146-153
48. Fogt F., Brien T., Brown C.A., Hartmann C.J., Zimmerman R.L., and Odze R.D. Genetic alterations in serrated adenomas: comparison to conventional adenomas and hyperplastic polyps. Hum Pathol 33 (2002) 87-91
49. Chung S.M., Chen Y., Panczykowski A., Klimstra D.A., and Yantiss R.K. Expanding the spectrum of sessile serrated adenoma. Mod Pathol 20 Suppl. 2 (2007) 111A
50. Chan T.L., Zhao W., Leung S.Y., and Yuen S.T. BRAF and KRAS mutations in colorectal hyperplastic polyps and serrated adenomas. Cancer Res 63 (2003) 4878-4881
51. Lazarus R., Junttila O.E., Karttunen T.J., and Makinen M.J. The risk of metachronous neoplasia in patients with serrated adenoma. Am J Clin Pathol 123 (2005) 349-359